StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — IDBI Capital

BUYEmcure Pharmaceuticals Limited

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))10 Sept 2026via IDBI Capital Research Calls Telegram

Entry₹1,954Stated
Target₹2,090
Total upside +6.96%
Stop loss₹1,889-3.33% risk
CMP₹1,994Just now
Active+2.05%+4.81%upside left 13d left
Follow IDBI Capital for new calls(28% target hit, 210 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 3 other Swing calls on EMCURESee 280 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 11 Sept, 2:02 pm IST
5 supporting2 neutral1 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·11 Sept · today

4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·11 Sept · today

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

NewsNdtv-Profit·7 Sept · 4d ago

(opens in new tab)

Broker’s call: Emcure Pharma (Buy)

NewsHbl·4 Sept · 6d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·8 Jul · 2mo ago

Neutral / worth noting (2)

Market Trading Guide: Emcure Pharma among 2 stock recommendations for Monday

NewsEt-Markets·6 Sept · 4d ago

(opens in new tab)

Coal India, Emcure Pharma, Finolex Cables, GIC, Gulf Oil Lubricants Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·3 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 72 — overbought territory

Technicals · rsi·11 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.